Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma announces positive pharmacokinetic data with Q-Octreotide

ABINGDON, England, April 26, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH; Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products in...
April 21, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech achieves positive dosing data for OpsiSporin Uveitis programme

ABINGDON, England, April 21, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
April 13, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015

Midatech will host a conference call and live Q&A session today (Wednesday 13 April 2016) at 1300 BST / 0800 EDT for analysts and investors to discuss the Annual Results. Dr Jim Phillips, Chief...
April 11, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US

ABINGDON, England, April 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH); (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing...
January 06, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma PLC (“Midatech”, the “Company” or the “Group”) Pre-Close Trading Update

OXFORD, United Kingdom, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising...
December 30, 2015 02:00 ET | Source: Midatech Pharma PLC

Midatech Completes Acquisition of Zuplenz®

OXFORDSHIRE, United Kingdom, Dec. 30, 2015 (GLOBE NEWSWIRE) -- Midatech Pharma (“Midatech” or the “Company” or the “Group”) (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical...
December 18, 2015 02:00 ET | Source: Midatech Pharma PLC

Midatech Agrees to Acquire Marketed Oncology Product, Zuplenz®, From Galena Biopharma, Inc.

OXFORDSHIRE, United Kingdom, Dec. 18, 2015 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH), the international specialty pharmaceutical company focused on developing and commercialising products in...